Anti-inflammatory effects of novel curcumin analogs in experimental acute lung injury

Respiratory Research

Volumn 16, Issue 1, 2015, Pages

  Zhang, Yali ^a   Liang, Dandan ^a   Dong, Lili ^a   Ge, Xiangting ^a   Xu, Fengli ^a   Chen, Wenbo ^a   Dai, Yuanrong ^a   Li, Huameng ^a   Zou, Peng ^b   Yang, Shulin ^b   Liang, Guang ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b NANJING UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Acute lung injury; Curcumin; ERK; LPS

Indexed keywords

CURCUMIN; CURCUMIN ANALOG; DRUG ANALOG; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; AUTACOID; IL1B PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; INTERLEUKIN-6, MOUSE; TUMOR NECROSIS FACTOR;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DRUG MECHANISM; DRUG SCREENING; DRUG STABILITY; DRUG SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HISTOPATHOLOGY; INFLAMMATORY CELL; LUNG EDEMA; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; RAT; ULTRAVIOLET SPECTROSCOPY; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; ANIMAL; BRONCHOALVEOLAR LAVAGE FLUID; CELL CULTURE; CHEMICALLY INDUCED; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECTS; ENZYME ACTIVATION; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; LUNG; METABOLISM; PATHOLOGY; PULMONARY EDEMA; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; TIME FACTOR;

ACUTE LUNG INJURY; ANIMALS; ANTI-INFLAMMATORY AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; CELLS, CULTURED; CURCUMIN; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LUNG; MACROPHAGES, PERITONEAL; MALE; MICE, INBRED ICR; MITOGEN-ACTIVATED PROTEIN KINASES; PULMONARY EDEMA; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84927748712     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/s12931-015-0199-1     Document Type: Article

References (49)

1. Johnson ER, Matthay MA. Acute lung injury: epidemiology, pathogenesis, and treatment. J Aerosol Med Pulm Drug Deliv 2010, 23:243-52. 10.1089/jamp.2009.0775, 20073554.
2. Wheeler AP, Bernard GR. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet 2007, 369:1553-64. 10.1016/S0140-6736(07)60604-7, 17482987.
3. Levitt JE, Matthay MA. Clinical review: early treatment of acute lung injury-paradigm shift toward prevention and treatment prior to respiratory failure. Crit Care 2012, 16:223. 10.1186/cc11144, 22713281.
4. Goodman RB, Pugin J, Lee JS, Matthay MA. Cytokine-mediated inflammation in acute lung injury. Cytokine Growth Factor Rev 2003, 14:523-35. 10.1016/S1359-6101(03)00059-5, 14563354.
5. Grommes J, Soehnlein O. Contribution of neutrophils to acute lung injury. Mol Med 2011, 17:293. 10.2119/molmed.2010.00138, 21046059.
6. Patel BV, Wilson MR, O'Dea KP, Takata M. TNF-induced death signaling triggers alveolar epithelial dysfunction in acute lung injury. J Immunol 2013, 190(8):4272-4282. 10.4049/jimmunol.1202437.
7. Bosmann M, Grailer JJ, Zhu K, Matthay MA, Sarma JV, Zetoune FS, et al. Anti-inflammatory effects of β2 adrenergic receptor agonists in experimental acute lung injury. FASEB J 2012, 26:2137-44. 10.1096/fj.11-201640, 22318967.
8. Ni Y-F, Wang J, Yan X-L, Tian F, Zhao J-B, Wang Y-J, et al. Histone deacetylase inhibitor, butyrate, attenuates lipopolysaccharide-induced acute lung injury in mice. Respir Res 2010, 11:33. 10.1186/1465-9921-11-33, 20302656.
9. Liu Z, Yang Z, Fu Y, Li F, Liang D, Zhou E, et al. Protective effect of gossypol on lipopolysaccharide-induced acute lung injury in mice. Inflamm Res 2013, 62:499-506. 10.1007/s00011-013-0603-6, 23435932.
10. Yingkun N, Zhenyu W, Jing L, Xiuyun L, Huimin Y. Stevioside protects LPS-induced acute lung injury in mice. Inflammation 2013, 36:242-50. 10.1007/s10753-012-9540-8, 22968433.
11. Calfee CS, Matthay MA. Nonventilatory treatments for acute lung injury and ARDS*. Chest J 2007, 131:913-20. 10.1378/chest.06-1743.
12. Levitt JE, Matthay MA. Treatment of Acute Lung Injury: Historical Perspective and Potential Future Therapies. In Seminars in Respiratory and Critical Care Medicine. Copyright© 2006 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.; 2006: 426-437..
13. O'Neal HR, Koyama T, Koehler EA, Siew E, Curtis BR, Fremont RD, et al. Prehospital statin and aspirin use and the prevalence of severe sepsis and ALI/ARDS. Crit Care Med 2011, 39:1343. 10.1097/CCM.0b013e3182120992, 21336116.
14. Ando H, Takamura T, Ota T, Nagai Y, Kobayashi K-I. Cerivastatin improves survival of mice with lipopolysaccharide-induced sepsis. J Pharmacol Exp Ther 2000, 294:1043-6. 10945857.
15. Jacobson JR, Barnard JW, Grigoryev DN, Ma S-F, Tuder RM, Garcia JG. Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury. Am J Physiol-Lung Cellular Mol Physiol 2005, 288:L1026-32. 10.1152/ajplung.00354.2004.
16. Leitman IM. Curcumin for the prevention of acute lung injury in sepsis: is it more than the flavor of the month?. J Surg Res 2012, 176:e5-7. 10.1016/j.jss.2011.11.1034, 22316673.
17. Liang G, Shao L, Wang Y, Zhao C, Chu Y, Xiao J, et al. Exploration and synthesis of curcumin analogues with improved structural stability both in vitro and in vivo as cytotoxic agents. Bioorg Med Chem 2009, 17:2623-31. 10.1016/j.bmc.2008.10.044, 19243951.
18. Prasad S, Tyagi AK, Aggarwal BB. Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice. Cancer Res Treat 2014, 46:2-18. 10.4143/crt.2014.46.1.2, 24520218.
19. Zhao C, Liu Z, Liang G. Promising curcumin-based drug design: mono-carbonyl analogues of curcumin (MACs). Curr Pharm Des 2013, 19:2114-35. 23116317.
20. Wu J, Zhang Y, Cai Y, Wang J, Weng B, Tang Q, et al. Discovery and evaluation of piperid-4-one-containing mono-carbonyl analogs of curcumin as anti-inflammatory agents. Bioorg Med Chem 2013, 21:3058-65. 10.1016/j.bmc.2013.03.057, 23611769.
21. Zhang Y, Zhao C, He W, Wang Z, Fang Q, Xiao B, et al. Discovery and evaluation of asymmetrical monocarbonyl analogs of curcumin as anti-inflammatory agents. Drug Design, Develop Therapy 2014, 8:373.
22. Pan Y, Huang Y, Wang Z, Fang Q, Sun Y, Tong C, et al. Inhibition of MAPK-mediated ACE expression by compound C66 prevents STZ-induced diabetic nephropathy. J Cell Mol Med 2014, 18:231-41. 10.1111/jcmm.12175, 24330074.
23. Pan Y, Zhang X, Wang Y, Cai L, Ren L, Tang L, et al. Targeting JNK by a new curcumin analog to inhibit NF-kB-mediated expression of cell adhesion molecules attenuates renal macrophage infiltration and injury in diabetic mice. PLoS One 2013, 8:e79084. 10.1371/journal.pone.0079084, 24260158.
24. Guzel A, Kanter M, Guzel A, Yucel AF, Erboga M. Protective effect of curcumin on acute lung injury induced by intestinal ischemia/reperfusion. Toxicol Ind Health 2013, 29(7):633-642. 10.1177/0748233711430984, 22252860.
25. Xu F, S-h L, Yang Y-Z, Guo R, Cao J, Liu Q. The effect of curcumin on sepsis-induced acute lung injury in a rat model through the inhibition of the TGF-β1/SMAD3 pathway. Int Immunopharmacol 2013, 16:1-6. 10.1016/j.intimp.2013.03.014, 23541743.
26. Xiao X, Yang M, Sun D, Sun S. Curcumin protects against sepsis-induced acute lung injury in rats. J Surg Res 2012, 176:e31-9. 10.1016/j.jss.2011.11.1032, 22520056.
27. Zhong W-T, Jiang L-X, Wei J-Y, Qiao A-N, Wei M-M, Soromou L-W, et al. Protective effect of esculentoside A on lipopolysaccharide-induced acute lung injury in mice. J Surg Res 2013, 185:364-72. 10.1016/j.jss.2013.05.018, 23764313.
28. Pan C, Wang J, Liu W, Liu L, Jing L, Yang Y, et al. Low tidal volume protects pulmonary vasomotor function from " second-hit" injury in acute lung injury rats. Respir Res 2012, 13:77. 10.1186/1465-9921-13-77, 22954351.
29. Wang Y-J, Pan M-H, Cheng A-L, Lin L-I, Ho Y-S, Hsieh C-Y, et al. Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal 1997, 15:1867-76. 10.1016/S0731-7085(96)02024-9, 9278892.
30. Goodman RB, Strieter RM, Martin DP, Steinberg KP, Milberg JA, Maunder RJ, et al. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1996, 154:602-11. 10.1164/ajrccm.154.3.8810593, 8810593.
31. Randhawa R, Bellingan G. Acute lung injury. Anaesth Intensive Care Med 2007, 8:477-80. 10.1016/j.mpaic.2007.09.003.
32. Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 2006, 354:1671-84. 10.1056/NEJMoa051693, 16625008.
33. Akdis M, Burgler S, Crameri R, Eiwegger T, Fujita H, Gomez E, et al. Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases. J Allergy Clin Immunol 2011, 127:701-21. e770, 10.1016/j.jaci.2010.11.050, 21377040.
34. Bouros D, Alexandrakis MG, Antoniou KM, Agouridakis P, Pneumatikos I, Anevlavis S, et al. The clinical significance of serum and bronchoalveolar lavage inflammatory cytokines in patients at risk for Acute Respiratory Distress Syndrome. BMC Pulm Med 2004, 4:6. 10.1186/1471-2466-4-6, 15315713.
35. van der Poll T, Keogh CV, Guirao X, Buurman WA, Kopf M, Lowry SF. Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia. J Infect Dis 1997, 176:439-44. 10.1086/514062, 9237710.
36. Chen J, Wang J-B, Yu C-H, Chen L-Q, Xu P, Yu W-Y. Total flavonoids of Mosla scabra leaves attenuates lipopolysaccharide-induced acute lung injury via down-regulation of inflammatory signaling in mice. J Ethnopharmacol 2013, 148:835-41. 10.1016/j.jep.2013.05.020, 23747643.
37. Liang D, Sun Y, Shen Y, Li F, Song X, Zhou E, et al. Shikonin exerts anti-inflammatory effects in a murine model of lipopolysaccharide-induced acute lung injury by inhibiting the nuclear factor-kappaB signaling pathway. Int Immunopharmacol 2013, 16:475-80. 10.1016/j.intimp.2013.04.020, 23651796.
38. Wan L-M, Tan L, Wang Z-R, Liu S-X, Wang Y-L, Liang S-Y, et al. Preventive and therapeutic effects of Danhong injection on lipopolysaccharide induced acute lung injury in mice. J Ethnopharmacol 2013, 149:352-9. 10.1016/j.jep.2013.06.048, 23850708.
39. Lu Y-C, Yeh W-C, Ohashi PS. LPS/TLR4 signal transduction pathway. Cytokine 2008, 42:145-51. 10.1016/j.cyto.2008.01.006, 18304834.
40. Lenardo MJ, Baltimore D. NF-κB: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 1989, 58:227-9. 10.1016/0092-8674(89)90833-7, 2665943.
41. Zhong F, Chen H, Han L, Jin Y, Wang W. Curcumin attenuates lipopolysaccharide-induced renal inflammation. Biol Pharm Bull 2011, 34:226-32. 10.1248/bpb.34.226, 21415532.
42. Seger R, Krebs EG. The MAPK signaling cascade. FASEB J 1995, 9:726-35. 7601337.
43. Kaminska B. MAPK signalling pathways as molecular targets for anti-inflammatory therapy-from molecular mechanisms to therapeutic benefits. Biochimica et Biophysica Acta (BBA)-Proteins Proteomics 2005, 1754:253-62. 10.1016/j.bbapap.2005.08.017.
44. Kim SH, Smith CJ, Van Eldik LJ. Importance of MAPK pathways for microglial pro-inflammatory cytokine IL-1β production. Neurobiol Aging 2004, 25:431-9. 10.1016/S0197-4580(03)00126-X, 15013563.
45. Zhan J, Liu Y, Zhang Z, Chen C, Chen K, Wang Y. Effect of penehyclidine hydrochloride on expressions of MAPK in mice with CLP-induced acute lung injury. Mol Biol Rep 2011, 38:1909-14. 10.1007/s11033-010-0310-0, 20845074.
46. Fein AM, Calalang-Colucci MG. Acute lung injury and acute respiratory distress syndrome in sepsis and septic shock. Crit Care Clin 2000, 16:289-317. 10.1016/S0749-0704(05)70111-1, 10768083.
47. Abraham E. Coagulation abnormalities in acute lung injury and sepsis. Am J Respir Cell Mol Biol 2000, 22:401-4. 10.1165/ajrcmb.22.4.f184, 10745020.
48. Reutershan J, Basit A, Galkina EV, Ley K. Sequential recruitment of neutrophils into lung and bronchoalveolar lavage fluid in LPS-induced acute lung injury. Am J Physiol-Lung Cellular Mol Physiol 2005, 289:L807-15. 10.1152/ajplung.00477.2004.
49. Coimbra R, Melbostad H, Loomis W, Porcides RD, Wolf P, Tobar M, et al. LPS-induced acute lung injury is attenuated by phosphodiesterase inhibition: effects on proinflammatory mediators, metalloproteinases, NF-[kappa] B, and ICAM-1 expression. J Trauma Injury Infection Critical Care 2006, 60:115-25. 10.1097/01.ta.0000200075.12489.74.